Obsessive‐compulsive Disorder and Treatment—One‐Year Follow up Study

Lydia Sushevska; Nichola Olumchev; Mirjana Saveska

Research paper

Published: 20.06.2011.

<< Prev | Next >>

PDF

Obsessive‐compulsive Disorder and Treatment—One‐Year Follow up Study

Abstract

Obsessive-compulsive disorder (OCD) is defined by the presence of either obsession or compulsion that is severe enough to be time consuming or to cause marked distress or significant impairment. At some point during the course of the disorder, the person recognizes that the obsessions and compulsions are excessive or unreasonable.
Twenty-one patients which all met the inclusion criteria for the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) for OCD diagnosis were observed in a private polyclinic in Skopje, Macedonia, treated with medications and evaluated on three separate occasions (baseline, after 6 months, and one year after the beginning of therapy). The severity of the obsessive-compulsive symptoms was assessed during each follow-up examination by means of the Yale-Brown Obsessive-Compulsive Scale (YBOCS), BDI (Beck depression inventory) and BAI (Beck anxiety inventory).
The aim of the present study was to investigate the changes in the psychiatric condition with the help of medications in patients with obsessive-compulsive disorder (OCD) over a one-year period of pharmacological treatment.
There was a statistically significant improvement of the scores of three subscales of Y-BOCS (obsession, compulsion, and global) in OCD patients during the one-year treatment. There was a statistically significant relationship between the time points and the BDI and BAI scores. They improved significantly between the six months and one-year time points.
Patients and their families should be provided with information on support groups and should have opportunities to discuss the impact the illness has had on their self-experience and their relationships.
Treatment with either selective serotonine re-uptake inhibitors (SSRIs) or cognitive-behavioural therapy (CBT), or both, is successful for OCD, which was confirmed in our study.

Keywords:

obsessive-compulsive disorder,

Yale-Brown Obsessive-Compulsive Scale,

selective serotonine re-uptake inhibitors,

treatment

References

Association AP. Diagnostic and Sta tistical Manual of Mental Disorders. 2000;

Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, RC S. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta analysis. Arch Gen Psychiatry. 1995;52(1):53–60.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ. Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis. Psy chopharmacol (Berl. 1998;136(3):205–16.

Nielen MM, Den Boer JA. Neuropsychological perfor mance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits. Psychol Med. 2003;33:917–25.

Sanz M, Molina V, Martin-Loeches M, Calcedo A, Rubia FJ. Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive compulsive disorder patients. Psychiatry Res. 2001;101:75–81.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, V C, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11(7):622–32.

LR B, JM S, KS B, MP S, BH G, JC M, et al. Caudate glucose meta bolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychia try. 1992;49(9):681–9.

Alonso P, Menchon JM, J P. Long-term fo llow-up and predictors of clinical outcome in obse ssive-compulsive patients treated with serotonin reup take inhibitors and behavioral therapy. J Clin Psychiatry. 2001;62:535–40.

The severity of the obsessive-compulsive symptoms was assessed during each follow-up examination by means of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS.